Compare RMD & LYV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMD | LYV |
|---|---|---|
| Founded | 1989 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 33.5B |
| IPO Year | 1995 | N/A |
| Metric | RMD | LYV |
|---|---|---|
| Price | $253.15 | $140.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 21 |
| Target Price | ★ $291.10 | $174.29 |
| AVG Volume (30 Days) | 880.0K | ★ 2.4M |
| Earning Date | 01-29-2026 | 02-19-2026 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | 29.59 | ★ 59.87 |
| EPS | ★ 9.77 | 1.38 |
| Revenue | $5,257,400,000.00 | ★ $24,569,494,000.00 |
| Revenue This Year | $9.85 | $9.23 |
| Revenue Next Year | $7.34 | $9.44 |
| P/E Ratio | ★ $26.36 | $104.82 |
| Revenue Growth | ★ 9.36 | 5.48 |
| 52 Week Low | $199.92 | $112.88 |
| 52 Week High | $293.81 | $175.25 |
| Indicator | RMD | LYV |
|---|---|---|
| Relative Strength Index (RSI) | 53.46 | 44.25 |
| Support Level | $240.00 | $143.58 |
| Resistance Level | $261.36 | $148.27 |
| Average True Range (ATR) | 5.40 | 3.29 |
| MACD | 1.27 | -0.47 |
| Stochastic Oscillator | 60.56 | 3.66 |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 45 countries, Live Nation promotes concerts globally and it owned, operated, or had exclusive booking rights to nearly 400 venues worldwide at the end of 2024, which the firm says makes it the second-largest operator of music venues globally. In 2024, Live Nation promoted nearly 55,000 events, drawing more than 150 million fans. Ticketmaster is a dominant global ticketing service, selling almost 640 million tickets in 2024.